weight loss glp 1 fda approved Approves Oral Semaglutide: First GLP-1 Pill FDA Approves New Weight Loss

Ozempic breasts describes changes in breast size, shape, and elasticity due to weight loss with Ozempic

The FDA has sent 30 warning letters to telehealth companies for falsely marketing compounded GLP-1s, which are not FDA-approved and can pose risks to patients.

Are GLP-1s already changing what youre seeing or are we still underestimating their role relative to other explanations

The medication, sold under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.

Plot your Ozempic, Wegovy, Mounjaro, or Zepbound doses and see your medication levels build up and taper week by week

GLP-1 medications may increase kidney stone risk through dehydration and uric acid changes, but individual risk depends on baseline kidney function, hydration status, and metabolic factors